Q-STATE BIOSCIENCES
Q-State Biosciences has developed an all-optical electrophysiology platform for controlling and recording activity in electrically active cells: primary and human iPSC-derived cardiomyocytes and neurons. The platform combines proprietary ultrasensitive optogenetic actuators, genetically encoded voltage indicators, stem cell technology and advanced optical imaging. Q-State Biosciences uses custom instrumentation and software to probe cellular physiology with sub-micron spatial resolution and sub-millisecond temporal resolution. Q-State technology probes dynamic cellular physiology with far higher throughput and information content than are achieved with manual patch clamp, multi electrode arrays, or calcium- or voltage-sensitive dyes.
Q-STATE BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.qstatebio.com
Total Employee:
11+
Status:
Active
Contact:
(617) 945-5433
Email Addresses:
[email protected]
Total Funding:
22.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Google Maps Cloudflare JS US Privacy User Signal Mechanism
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Athelas
Athelas develops technology to monitor chronically ill patients in their homes.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Catalent Pharma Solutions
Catalent provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies.
Daye
Daye creates category-defining products and services that set a new standard for medical research and scientific innovation.
Design Pharmaceuticals
Design Pharma has a unique suite of proprietary technologies that enable the discovery and biosynthetic production of drug candidates.
Edesa Biotech
Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.
ELSI Skin Health Inc. (dba Dr. Elsa Jungman)
We are redefining how women treat their skin. Research first, skincare second. First Microbiome-Friendly Skincare.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
Epalex
Epalex is developing a novel inhaled treatment for epilepsy and migraine.
FGen
FGen develops proprietary technologies and products in different biotechnological areas.
Flaskworks
Flaskworks is improves the manufacture of immuno-therapeutics and dendritic cell-based vaccines.
Generian Pharmaceuticals
Generian has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Nanalysis
Nanalysis develops portable nuclear magnetic resonance spectrometers for biotech and pharmaceutical applications.
Nuclera
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Numerate
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Pentixapharm
Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.
Psycheceutical
Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.
Quantum Thought
Quantum Thought is the world's leading venture studio for commercializing quantum computing intellectual property, products, and companies.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
SinoVeda Canada
SinoVeda Canada develops high quality nutraceuticals and prescription pharmaceuticals from botanical sources.
Soltego
Soltego is a biotechnology company leveraging the skin’s pigmentation power for therapeutic and aesthetic applications.
SuperBrewed Food
SuperBrewed Food(formerlyWhite Dog Labs) is developing new probiotics for animals and human.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-11-30 | Pairnomix | Pairnomix acquired by Q-State Biosciences | N/A |
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Q-State Biosciences
Official Site Inspections
http://www.qstatebio.com Semrush global rank: 3.93 M Semrush visits lastest month: 3.19 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Q-State Biosciences"
Q-State Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (617) 945-5433 Q-State Biosciences has developed an all-optical electrophysiology platform for controlling and recording activity in …See details»
Q-State Biosciences Announces Achievement of Key …
Feb 8, 2021 Business Development Chani Maher [email protected] +1 617-945-5433 Release Summary Q-State Biosciences announces achievement of primary program completion milestone in research ...See details»
Leadership Team | q-state - qstatebio.wixsite.com
DAVID MARGULIES, MD, Co-founder & Chairman of the Board - David Margulies is a physician executive and entrepreneur with career-long interests in computational biology and the …See details»
About Q-State Biosciences | q-state
Q-State Biosciences has developed an all-optical electrophysiology platform for controlling and recording activity in electrically active cells: primary and human iPSC-derived cardiomyocytes …See details»
Q-State Biosciences Announces Key Appointments to Its Executive ...
For more information, please visit www.qstatebio.com. Contacts. Business Development Chani Maher [email protected] +1 617-945-5433. Media Carolyn Noyes …See details»
Q-State Biosciences Announces New Therapeutic Programs …
Oct 6, 2021 For more information, please visit www.qstatebio.com. Contacts. Business Development Chani Maher [email protected] +1 617-945-5433 Media Carolyn …See details»
Q-State Biosciences Announces New Therapeutic Programs …
CAMBRIDGE, MASSACHUSETTS--(BUSINESS WIRE)--Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of …See details»
The Silverstein Foundation and Q-State Biosciences Launch …
Q-State Biosciences is a precision medicine company based in Cambridge, MA, that pioneers revolutionizing care for patients with devastating genetic disorders. Q-State applies a …See details»
Q-State Biosciences Announces New Therapeutic Programs
Oct 6, 2021 By integrating advanced human neuronal models, custom determinative measurement engineering and powerful AI/machine learning, we unlock unique insights into …See details»
Q-State Biosciences Announces the Appointment of Biopharma …
Oct 5, 2020 For more information, please visit www.qstatebio.com. Contacts Media Shai Biran [email protected] +1 781-235-3060 Business Development Wendell Taylor …See details»
Q-State Biosciences Announces the Appointment of Biopharma
Oct 5, 2020 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Q-State Biosciences (“Q-State”), a precision therapeutics company developing treatments for diseases associated with …See details»
Q-State Biosciences Announces Additions and Appointments to its …
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences (“Q-State”), a precision therapeutics company developing treatments for diseases associated with electrically excitable …See details»
Q-State Biosciences Announces Achievement of Key Research …
Feb 8, 2021 For more information, please visit www.qstatebio.com. About Chamishi Therapeutics . ... The Silverstein Foundation is a 501(c)(3) non-profit organization focused on …See details»
Q-State Biosciences Announces Presentation at the World Orphan …
Aug 24, 2021 For more information, please visit www.qstatebio.com. Contacts. Business Development Chani Maher [email protected] +1 617-945-5433 Media Carolyn …See details»
Q-State Biosciences Closes Series A Financing And Combines With ...
CAMBRIDGE, Mass., Nov. 29, 2018 /PRNewswire/ -- Q-State Biosciences, Inc. ("Q-State") today announced it has closed its Series A financing and has joined with Minneapolis-based …See details»
Q-State Biosciences Awarded NIH Grant for the Development of
Jul 20, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of …See details»
Q-State Biosciences Announces Pre-Clinical Proof-of-Concept …
Jun 28, 2021 For more information, please visit www.qstatebio.com. Contacts. Business Development Chani Maher [email protected] +1 617-945-5433 Media Carolyn …See details»
Q-State Biosciences Announces New Peer Reviewed Publication …
July 13, 2022, CAMBRIDGE, MASSACHUSETTS--(BUSINESS WIRE)--Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the …See details»
Q-State Biosciences Achieves Milestone of 50 Million Neurons
May 10, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Q-State Biosciences (“Q-State”), a therapeutics and discovery technology company advancing programs for the treatment of …See details»
Home - Quiver Bioscience
The name change reflects our readiness and focus to bring new drugs for neurological disease targets to the clinic. After nearly a decade of science and engineering advancements, Quiver …See details»